Atlas Trials

Rosuvastatin Adherence App Study in China

Clinical trial NCT02433288 · COMPLETED

Trial details

NCT number
NCT02433288
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DyslipidemiaHyperlipidemia
Start date
2015-07-20
Primary completion
2016-10-28
Enrollment
885

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.